Correlation Between Preoperative NT-proBNP and Postoperative AKI
Correlation Between the Preoperative N-terminal Pro-B-type Natriuretic Peptide and Acute Kidney Injury After Abdominal Surgery: a Single Center Retrospective Cohort Study Based on ERAS Database
1 other identifier
observational
629
1 country
1
Brief Summary
Accurate preoperative AKI risk prediction is of great significance for improving patient outcomes. The use of preoperative NT-proBNP can provide a more precise assessment of the body's fluid load status, guide intraoperative and postoperative fluid management, and thus reduce fluid related postoperative complications. Given the potential association between ERAS and increased postoperative AKI, we hypothesize that preoperative NT-proBNP may be associated with the development of postoperative AKI in ERAS, and can improve the prediction of AKI beyond traditional clinical risk factors. This study aims to validate this hypothesis and provide evidence for using NT-proBNP to assess AKI risk before non cardiac surgery. Improve the predictive ability of clinical predictive models and optimize ERAS protocols to prevent postoperative AKI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2023
CompletedFirst Submitted
Initial submission to the registry
September 14, 2023
CompletedFirst Posted
Study publicly available on registry
November 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedAugust 16, 2024
August 1, 2024
12 months
September 14, 2023
August 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of AKI assessed by KDIGO 2012 (Kidney Disease: Improving Global Outcomes)
Postoperative incidence of AKI, serum creatinine increases≥ 0.3mg/dL (≥ 26.5 μ Mol/L) within 48 hours, or the serum creatinine increases to 1.5 times or more of the baseline value within 7 days.
1 week
Secondary Outcomes (2)
AKI grading assessed by KDIGO 2012 (Kidney Disease: Improving Global Outcomes)
1 week
Morbidity
4 week
Study Arms (2)
Acute kidney injury group
Patients developed acute kidney injury.
Non-Acute kidney injury group
Patients didn't develope acute kidney injury.
Eligibility Criteria
Patients with normal renal function undergoing elective abdominal surgery
You may qualify if:
- ≥18 years
- undergoing elective surgery
- Have a history of NT-proBNP and creatinine testing within 7 days before surgery
You may not qualify if:
- Patients undergoing chronic peritoneal or hemodialysis treatment; patients who have undergone kidney transplantation; preoperative serum creatinine levels\>4.5mg/dL (400 μ Mol/L) or end-stage renal disease patient (defined as glomerular filtration rate\<15ml • min-1 • 1.73m-2)
- Organ transplantation surgery
- Pregnant patients
- Surgical duration\<1 hour
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xijing Hospitallead
Study Sites (1)
Xijing Hospital
Xi'an, Shaanxi, 710032, China
Related Publications (2)
Ojo B, Campbell CH. Perioperative acute kidney injury: impact and recent update. Curr Opin Anaesthesiol. 2022 Apr 1;35(2):215-223. doi: 10.1097/ACO.0000000000001104.
PMID: 35102042BACKGROUNDZhang Z, Zheng Z, Nie H, Dong H, Lei C. Association between the preoperative N-terminal pro-B-type natriuretic peptide and acute kidney injury in gastrointestinal surgery patients managed with enhanced recovery strategy: a retrospective cohort study. Perioper Med (Lond). 2025 Apr 22;14(1):45. doi: 10.1186/s13741-025-00528-6.
PMID: 40264198DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hailong Dong
Xijing Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator, Head of Anesthesia Clinical Research Center, Xijing Hospital
Study Record Dates
First Submitted
September 14, 2023
First Posted
November 24, 2023
Study Start
July 10, 2023
Primary Completion
July 1, 2024
Study Completion
July 1, 2024
Last Updated
August 16, 2024
Record last verified: 2024-08